Condensed Consolidated Statements of Changes in Equity (Deficiency) (Unaudited) - USD ($)		Preferred Stock	Common Stock		Additional paid-in capital	Treasury Stock		Subscription receivable	Accumulated deficit	Accumulated other comprehensive loss	Noncontrolling interest	Total
Balance at Jun. 30, 2019			$ 26,523,830		$ 2,066,906	$ (417,538)			$ (6,968,700)	$ (671,106)	$ (5,173,622)	$ 15,359,770
Balance (in Shares) at Jun. 30, 2019			3,210,907	[1]		(35,099)	[1]
Stock based compensation to employee			$ 63,000									63,000
Stock based compensation to employee (in Shares)			18,000	[1]			[1]
Stock based compensation to consultants			$ 200,300									200,300
Stock based compensation to consultants (in Shares)			48,000	[1]			[1]
Amortization of shares issued to consultants					180,209							180,209
Foreign currency translation										(646,211)	142,544	(503,667)
Net loss									(1,627,353)		(121,271)	(1,748,624)
Balance at Sep. 30, 2019			$ 26,787,130		2,247,115	$ (417,538)			(8,596,053)	(1,317,317)	(5,152,349)	13,550,988
Balance (in Shares) at Sep. 30, 2019	[1]		3,276,907			(35,099)
Balance at Jun. 30, 2019			$ 26,523,830		2,066,906	$ (417,538)			(6,968,700)	(671,106)	(5,173,622)	15,359,770
Balance (in Shares) at Jun. 30, 2019			3,210,907	[1]		(35,099)	[1]
Net loss												(6,314,972)
Balance at Mar. 31, 2020			$ 28,090,992		2,334,962			(114,054)	(12,821,480)	(1,142,737)	(5,524,315)	10,823,368
Balance (in Shares) at Mar. 31, 2020	[1]		3,627,808
Balance at Sep. 30, 2019			$ 26,787,130		2,247,115	$ (417,538)			(8,596,053)	(1,317,317)	(5,152,349)	13,550,988
Balance (in Shares) at Sep. 30, 2019	[1]		3,276,907			(35,099)
Stock based compensation to employee			$ 156,400									156,400
Stock based compensation to employee (in Shares)	[1]		46,000
Stock based compensation to consultants			$ 282,500									282,500
Stock based compensation to consultants (in Shares)	[1]		70,000
Amortization of shares issued to consultants					52,708							52,708
Issuance of common stock to private investor			$ 500,500									500,500
Issuance of common stock to private investor (in Shares)	[1]		100,100
Cancellation of treasury stock			$ (417,538)			$ 417,538
Cancellation of treasury stock (in Shares)	[1]		(35,099)			35,099
Foreign currency translation										350,015	(93,809)	256,206
Net loss									(407,333)		43,978	(363,355)
Balance at Dec. 31, 2019			$ 27,308,992		2,299,823				(9,003,386)	(967,302)	(5,202,180)	14,435,947
Balance (in Shares) at Dec. 31, 2019	[1]		3,457,908
Stock based compensation to consultants			$ 282,500									282,500
Stock based compensation to consultants (in Shares)	[1]		70,000
Amortization of shares issued to consultants					35,139							35,139
Issuance of common stock to private investor			$ 499,500					(114,054)				385,446
Issuance of common stock to private investor (in Shares)	[1]		99,900
Foreign currency translation										(175,435)	62,764	(112,671)
Net loss									(3,818,094)		(384,899)	(4,202,993)
Balance at Mar. 31, 2020			$ 28,090,992		2,334,962			(114,054)	(12,821,480)	(1,142,737)	(5,524,315)	10,823,368
Balance (in Shares) at Mar. 31, 2020	[1]		3,627,808
Balance at Jun. 30, 2020			$ 28,414,992		2,334,962			(59,869)	(23,421,594)	(1,084,030)	(6,542,361)	(357,900)
Balance (in Shares) at Jun. 30, 2020			3,718,788	[1]
Issuance of common stock to private investor			$ 1,051,200					59,869				1,111,069
Issuance of common stock to private investor (in Shares)			720,000	[1]
Foreign currency translation										191,251	(198,824)	(7,573)
Net loss									(733,791)		(14,665)	(748,456)
Balance at Sep. 30, 2020			$ 29,466,192		2,334,962				(24,155,385)	(892,779)	(6,755,850)	(2,860)
Balance (in Shares) at Sep. 30, 2020	[1]		4,438,788
Balance at Jun. 30, 2020			$ 28,414,992		2,334,962			(59,869)	(23,421,594)	(1,084,030)	(6,542,361)	(357,900)
Balance (in Shares) at Jun. 30, 2020			3,718,788	[1]
Net loss												(5,360,965)
Balance at Mar. 31, 2021			$ 82,555,700		2,334,962				(28,739,565)	(733,247)	(6,969,926)	48,447,924
Balance (in Shares) at Mar. 31, 2021			14,961,999	[1]			[1]
Balance at Sep. 30, 2020			$ 29,466,192		2,334,962				(24,155,385)	(892,779)	(6,755,850)	(2,860)
Balance (in Shares) at Sep. 30, 2020	[1]		4,438,788
Issuance of preferred stock to private investor		$ 1,427,600										1,427,600
Issuance of preferred stock to private investor (in Shares)		860,000
Issuance of common stock to private investor			$ 4,322,330									4,322,330
Issuance of common stock to private investor (in Shares)	[1]		1,560,000
Foreign currency translation										235,865	(204,827)	31,038
Net loss									(1,102,919)		9,359	(1,093,560)
Balance at Dec. 31, 2020		$ 1,427,600	$ 33,788,522		2,334,962				(25,258,304)	(656,914)	(6,951,318)	4,684,548
Balance (in Shares) at Dec. 31, 2020		860,000	5,998,788	[1]			[1]
Issuance of common stock to private investor			$ 42,535,678									42,535,678
Issuance of common stock to private investor (in Shares)	[1]		6,740,456
Conversion of preferred stock into common stock		$ (1,427,600)	$ 1,427,600
Conversion of preferred stock into common stock (in Shares)		(860,000)	860,000	[1]
Exercise of stock warrants			$ 4,803,900									4,803,900
Exercise of stock warrants (in Shares)	[1]		1,362,755
Foreign currency translation										(76,333)	19,080	(57,253)
Net loss									(3,481,261)		(37,688)	(3,518,949)
Balance at Mar. 31, 2021			$ 82,555,700		$ 2,334,962				$ (28,739,565)	$ (733,247)	$ (6,969,926)	$ 48,447,924
Balance (in Shares) at Mar. 31, 2021			14,961,999	[1]			[1]

[1] Shares and per share data are presented on a retroactive basis to reflect the 1-for-5 reverse stock split on July 7, 2020.